|
Figure 2
Selection of crystalline batch suspensions using SHG imaging microscopy. Rhodopsin batch crystallization trials [precipitant: 0.15 M DL-malic acid pH 7.0, 20%(w/v) PEG 3350] from the vials in Fig. 1 ![]() |
|
Figure 2
Selection of crystalline batch suspensions using SHG imaging microscopy. Rhodopsin batch crystallization trials [precipitant: 0.15 M DL-malic acid pH 7.0, 20%(w/v) PEG 3350] from the vials in Fig. 1 ![]() |